Related references
Note: Only part of the references are listed.Subclinical renal involvement in essential cryoglobulinemic vasculitis and classic polyarteritis nodosa
Tamer A. Gheita et al.
JOINT BONE SPINE (2012)
Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis
Y. Masui et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis
Minoru Hasegawa et al.
CLINICAL RHEUMATOLOGY (2011)
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement
Pia Moinzadeh et al.
EXPERIMENTAL DERMATOLOGY (2011)
High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis
Olga Kaloudi et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Four-Gene Biomarker Predicts Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
G. Farina et al.
ARTHRITIS AND RHEUMATISM (2010)
Skin score: A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis
Philip J. Clements et al.
ARTHRITIS AND RHEUMATISM (2010)
SERUM PROTEOME OF PATIENTS WITH SYSTEMIC SCLEROSIS: MOLECULAR ANALYSIS OF EXPRESSION AND PREVALENCE OF HAPTOGLOBIN ALPHA CHAIN ISOFORMS
R. Guerranti et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
Mechanisms of skin fibrosis in systemic sclerosis
Masatoshi Jinnin
JOURNAL OF DERMATOLOGY (2010)
A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity
Jennifer L. Sargent et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury
Sarah A. Pendergrass et al.
PLOS ONE (2010)
Comparative Proteomic Analysis of Serum from Patients with Systemic Sclerosis and Sclerodermatous GVHD. Evidence of Defective Function of Factor H
Cinzia Scambi et al.
PLOS ONE (2010)
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial
Silvia Bosello et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor β
G. Farina et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Effector CD8+ T Cells in Systemic Sclerosis Patients Produce Abnormally High Levels of Interleukin-13 Associated With Increased Skin Fibrosis
Patrizia Fuschiotti et al.
ARTHRITIS AND RHEUMATISM (2009)
Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?
Nicoletta Carlo-Stella et al.
CLINICAL RHEUMATOLOGY (2009)
Increased Serum Pentraxin 3 in Patients with Systemic Sclerosis
Yohei Iwata et al.
JOURNAL OF RHEUMATOLOGY (2009)
Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis
J. H. W. Distler et al.
RHEUMATOLOGY (2009)
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis-assessment of individual body sites in two large randomized controlled trials
Marian Kaldas et al.
RHEUMATOLOGY (2009)
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
Pravitt Gourh et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?
Andrew Leask et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Stem cell transplantation: a treatment option for severe systemic sclerosis?
J. M. van Laar et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma
Hangjun Duan et al.
ARTHRITIS AND RHEUMATISM (2008)
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A. Merkel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Src kinases in systemic sclerosis
Catherine Skhirtladze et al.
ARTHRITIS AND RHEUMATISM (2008)
The role of radiology in the management of systemic sclerosis
G. Madani et al.
CLINICAL RADIOLOGY (2008)
Connective tissue growth factor: Structure-function relationships of a mosaic, multifunctional protein
Patricia De Winter et al.
GROWTH FACTORS (2008)
Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
Ausra Milano et al.
PLOS ONE (2008)
Role of PDGF in fibrotic diseases and systemic sclerosis
M. Trojanowska
RHEUMATOLOGY (2008)
High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease
R. Hesselstrand et al.
RHEUMATOLOGY (2008)
Quantification of hardness, elasticity and viscosity of the skin of patients with systemic sclerosis using a novel sensing device (Vesmeter): a proposal for a new outcome measurement procedure
Y. Kuwahara et al.
RHEUMATOLOGY (2008)
Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc
D. Abraham
RHEUMATOLOGY (2008)
COMP:: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
R. Hesselstrand et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Stimulatory autoantibodies to the PDGF receptor: A link to fibrosis in scleroderma and a pathway for novel therapeutic targets
Armando Gabrielli et al.
AUTOIMMUNITY REVIEWS (2007)
Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases
Takashi Matsushita et al.
EXPERIMENTAL DERMATOLOGY (2007)
Systemic sclerosis: a prototypic multisystem fibrotic disorder
John Varga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Durometry for the assessment of skin disease in systemic sclerosis
Eugene Y. Kissin et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Adenosine A2A receptors in diffuse dermal fibrosis pathogenic role in human dermal fibroblasts and in a murine model of scleroderma
E. S. L. Chan et al.
ARTHRITIS AND RHEUMATISM (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts
Giuseppina Farina et al.
MATRIX BIOLOGY (2006)
A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis
O Nadashkevich et al.
CLINICAL RHEUMATOLOGY (2006)
Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis
Y Asano et al.
RHEUMATOLOGY (2006)
Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
K Yanaba et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Elevated serum BAFF levels in patients with systemic sclerosis - Enhanced BAFF signaling in systemic sclerosis B lymphocytes
T Matsushita et al.
ARTHRITIS AND RHEUMATISM (2006)
Circulating levels of active transforming growth factor β1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score
M Dziadzio et al.
RHEUMATOLOGY (2005)
Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: Important pathogenetic steps in early and late stage of systemic scleroderma?
J Brinckmann et al.
MATRIX BIOLOGY (2005)
N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma
M Dziadzio et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
WU Kim et al.
ARTHRITIS RESEARCH & THERAPY (2005)
TGF-β signaling and the fibrotic response
A Leask et al.
FASEB JOURNAL (2004)
Cytokine and chemokine levels in systemic sclerosis:: relationship with cutaneous and internal organ involvement
E Scala et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis
A Åkesson et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Seventeen-point dermal ultrasound scoring system - a reliable measure of skin thickness in patients with systemic sclerosis
TL Moore et al.
RHEUMATOLOGY (2003)
Non-invasive measurement of biomechanical skin properties in systemic sclerosis
A Balbir-Gurman et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis
S Sato et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2001)
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis:: procedure related mortality and impact on skin disease
M Binks et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Circulating collagen metabolites in systemic sclerosis.: Differences between limited and diffuse form and relationship with pulmonary involvement
A Scheja et al.
RHEUMATOLOGY (2000)
Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis
N Yazawa et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Share Paper
